We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CONMED Corporation | NYSE:CNMD | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.88 | 1.20% | 74.04 | 74.48 | 73.05 | 73.05 | 177,112 | 22:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
|
||
(Address of principal executive offices) | (Zip code) |
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Rule 12(b) of the Act
Title of each class |
Trading Symbol |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 | Financial Regulation FD Disclosure. |
On September 30, 2024, CONMED Corporation (the “Company”) issued the following statement on the impact from Hurricane Helene on the Company’s operations:
The path of Hurricane Helene impacted the Company’s manufacturing facility in Largo, Florida and the Company’s distribution center in Lithia Springs, Georgia. The Company prioritizes the safety of its employees, and ceased manufacturing operations at its Largo, Florida facility for approximately 24 hours. Employee absences at the Largo facility were significant after the storm had passed, temporarily impacting the facility’s manufacturing. As of September 30, 2024, the Company has confirmed that all employees are safe, and no significant damage was reported at either facility, and both facilities are back to normal operations.
The Company also understands that its customers in the southeastern United States delayed surgeries and other activity due to the storm, and some areas continue to be affected. The Company is unable to estimate the financial impact of Hurricane Helene at this time.
The information contained in this Item 7.01 is being “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). The information in this Item 7.01 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act or into any filing or other document pursuant to the Exchange Act, except as otherwise expressly stated in any such filing.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: September 30, 2024 | CONMED CORPORATION | |||||
(Registrant) | ||||||
By: | /s/ Todd W. Garner | |||||
Name: | Todd W. Garner | |||||
Title: | Executive Vice President-Chief Financial Officer |
Document and Entity Information |
Sep. 30, 2024 |
---|---|
Cover [Abstract] | |
Entity Registrant Name | CONMED Corp |
Amendment Flag | false |
Entity Central Index Key | 0000816956 |
Document Type | 8-K |
Document Period End Date | Sep. 30, 2024 |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-39218 |
Entity Tax Identification Number | 16-0977505 |
Entity Address, Address Line One | 11311 Concept Blvd |
Entity Address, City or Town | Largo |
Entity Address, State or Province | FL |
Entity Address, Postal Zip Code | 33773 |
City Area Code | (727) |
Local Phone Number | 392-6464 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.01 par value |
Trading Symbol | CNMD |
Security Exchange Name | NYSE |
Entity Emerging Growth Company | false |
1 Year CONMED Chart |
1 Month CONMED Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions